Oral leukoplakia in the Sudan: clinicopathological features and risk factors
- PMID: 31407319
- PMCID: PMC9379077
- DOI: 10.1111/idj.12509
Oral leukoplakia in the Sudan: clinicopathological features and risk factors
Abstract
Objectives: To analyse the clinical and histopathological features of oral leukoplakia (OL) in the Sudan, and to identify the risk factors associated with dysplastic and malignant changes.
Methods: Records of 117 cases with the diagnosis of OL at the Department of Oral Pathology in the period from 2010 to 2017 were reviewed.
Results: Of the 117 cases included in this study, 30 cases (25.6%) showed carcinoma in the initial diagnostic biopsy. The mean age at diagnosis was 59.8 years with a male/female ratio of 3.3:1. The lip (48.7%) and the gingiva (31.6%) were the predominantly affected sites. Multivariate regression analysis revealed that females were associated with 3.36-fold [95% confidence interval (CI), 1.36-10.76; P = 0.012] higher risk of malignant transformation compared with males. Verrucous leukoplakia was associated with 3.38-fold (95% CI, 1.12-10.19; P = 0.031) higher risk of malignant transformation compared with homogeneous leukoplakia. Exclusive Toombak dipping was the significant risk factor for the presence of dysplasia in OL (odds ratio, 9.35; 95% CI, 1.28-67.99; P = 0.027).
Conclusions: Clinical and histopathological features of OL were analysed and correlated. Toombak dipping was the significant risk factor for dysplastic changes, while female gender and verrucous leukoplakia were the factors associated with malignant transformation.
Keywords: Oral leukoplakia; Toombak; dysplasia; malignant transformation; risk factors.
© 2019 FDI World Dental Federation.
Figures


Similar articles
-
Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.BMC Cancer. 2010 Dec 16;10:685. doi: 10.1186/1471-2407-10-685. BMC Cancer. 2010. PMID: 21159209 Free PMC article.
-
Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.Oral Oncol. 2020 Nov;110:105014. doi: 10.1016/j.oraloncology.2020.105014. Epub 2020 Oct 7. Oral Oncol. 2020. PMID: 33038723
-
Oral leukoplakia: A clinicopathological study and malignant transformation.Oral Dis. 2023 May;29(4):1454-1463. doi: 10.1111/odi.14123. Epub 2022 Jan 20. Oral Dis. 2023. PMID: 34982498
-
Hospital-based epidemiological and clinical characterisation of the malignant transformation of oral leukoplakia in a Chinese population.Int Dent J. 2017 Aug;67(4):252-259. doi: 10.1111/idj.12292. Epub 2017 Mar 9. Int Dent J. 2017. PMID: 28276054 Free PMC article. Review. English.
-
Is toombak a risk factor for oral leukoplakia and oral squamous cell carcinoma ? A systematic review.J Oral Pathol Med. 2020 Feb;49(2):103-109. doi: 10.1111/jop.12954. Epub 2019 Sep 16. J Oral Pathol Med. 2020. PMID: 31436350
Cited by
-
A Retrospective Cohort Study of Oral Leukoplakia in Female Patients-Analysis of Risk Factors Related to Treatment Outcomes.Int J Environ Res Public Health. 2021 Aug 6;18(16):8319. doi: 10.3390/ijerph18168319. Int J Environ Res Public Health. 2021. PMID: 34444068 Free PMC article.
-
Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.Int Dent J. 2024 Jun;74(3):581-588. doi: 10.1016/j.identj.2023.12.011. Epub 2024 Jan 26. Int Dent J. 2024. PMID: 38278714 Free PMC article.
References
-
- Idris AM, Ahmed HM, Mukhtar BI, et al. Descriptive epidemiology of oral neoplasms in Sudan 1970–1985 and the role of toombak. Int J Cancer. 1995;61:155–158. - PubMed
-
- Idris AM, Prokopczyk B, Hoffmann D. Toombak: a major risk factor for cancer of the oral cavity in Sudan. Prev Med. 1994;23:832–839. - PubMed
-
- Costea DE, Lukandu O, Bui L, et al. Adverse effects of Sudanese toombak vs. Swedish snuff on human oral cells. J Oral Pathol Med. 2010;39:128–140. - PubMed
-
- Idris AM, Ibrahim SO, Vasstrand EN, et al. The Swedish snus and the Sudanese toombak: are they different? Oral Oncol. 1998;34:558–566. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources